NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues
The CCN family of genes presently consists of six distinct members encoding proteins that participate in fundamental biological processes such as cell proliferation, attachment, migration, differentiation, wound healing, angiogenesis, and several pathologies including fibrosis and tumorigenesis. Whe...
Gespeichert in:
Veröffentlicht in: | MP. Molecular pathology 2001-04, Vol.54 (2), p.57-79 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 79 |
---|---|
container_issue | 2 |
container_start_page | 57 |
container_title | MP. Molecular pathology |
container_volume | 54 |
creator | Perbal, B |
description | The CCN family of genes presently consists of six distinct members encoding proteins that participate in fundamental biological processes such as cell proliferation, attachment, migration, differentiation, wound healing, angiogenesis, and several pathologies including fibrosis and tumorigenesis. Whereas CYR61 and CTGF were reported to act as positive regulators of cell growth, NOV (nephroblastoma overexpressed) provided the first example of a CCN protein with negative regulatory properties and the first example of aberrant expression being associated with tumour development. The subsequent discovery of the ELM1, rCOP1, and WISP proteins has broadened the variety of functions attributed to the CCN proteins and has extended previous observations to other biological systems. This review discusses fundamental questions regarding the regulation of CCN gene expression in normal and pathological conditions, and the structural basis for their specific biological activity. After discussing the role of nov and other CCN proteins in the development of a variety of different tissues such as kidney, nervous system, muscle, cartilage, and bone, the altered expression of the CCN proteins in various pathologies is discussed, with an emphasis on the altered expression of nov in many different tumour types such as Wilms's tumour, renal cell carcinomas, prostate carcinomas, osteosarcomas, chondrosarcomas, adrenocortical carcinomas, and neuroblastomas. The possible use of nov as a tool for molecular medicine is also discussed. The variety of biological functions attributed to the CCN proteins has led to the proposal of a model in which physical interactions between the amino and carboxy portions of the CCN proteins modulate their biological activity and ensure a proper balance of positive and negative signals through interactions with other partners. In this model, disruption of the secondary structure of the CCN proteins induced by deletions of either terminus is expected to confer on the truncated polypeptide constitutive positive or negative activities. |
doi_str_mv | 10.1136/mp.54.2.57 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1187006</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A75453322</galeid><sourcerecordid>A75453322</sourcerecordid><originalsourceid>FETCH-LOGICAL-b572t-8c776bb987bfa63bfbd676b99d86850e394526f4dfd0bf3c9ea5f03f75c413b93</originalsourceid><addsrcrecordid>eNp90l1v0zAUBuAIgdgY3PADUAQCAaLFTvyRcIE0RXxNU3cD0-6M7Ry3Hokd7GTa_j0urbohVSgXTuzHb46PnGVPMZpjXLL3_TCnZF7MKb-XHWLCixnBlNxP7yVjs4pjcpA9ivESIVSRonqYHaRtRYEZP8x-Ls7O89cOhlXwqpNx9L3M_RUEuB4CxAjtm1y6Nh9XkDfNIjeyt91N7k2-BAfxQx7HMOlxCrL768zk9Gi9S582xgni4-yBkV2EJ9vxKPvx-dP35uvs9OzLt-b4dKYoL8ZZpTlnStUVV0ayUhnVsjRR123FKoqgrAktmCGtaZEypa5BUoNKw6kmuFR1eZR93OQOk-qh1eDGVJMYgu1luBFeWvHvirMrsfRXAuOKI8RSwKttQPC_U-Gj6G3U0HXSgZ-i4IjXNUZlgs83cCk7ENYZn_L0GotjTgktU28TercHrXuW_u0dGJum7_LZHp6eFnqr9_m3G6-DjzGA2R0UI7G-FKIfBCWiEJQn_Oxua27p9hYk8GILZNSyM0E6bePO1YTUBN3WaOMI17tVGX6JlMGpWJw3YnFxgU4aRsRJ8i83XvWX_yvvD4-_2hI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70799103</pqid></control><display><type>article</type><title>NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Perbal, B</creator><creatorcontrib>Perbal, B</creatorcontrib><description>The CCN family of genes presently consists of six distinct members encoding proteins that participate in fundamental biological processes such as cell proliferation, attachment, migration, differentiation, wound healing, angiogenesis, and several pathologies including fibrosis and tumorigenesis. Whereas CYR61 and CTGF were reported to act as positive regulators of cell growth, NOV (nephroblastoma overexpressed) provided the first example of a CCN protein with negative regulatory properties and the first example of aberrant expression being associated with tumour development. The subsequent discovery of the ELM1, rCOP1, and WISP proteins has broadened the variety of functions attributed to the CCN proteins and has extended previous observations to other biological systems. This review discusses fundamental questions regarding the regulation of CCN gene expression in normal and pathological conditions, and the structural basis for their specific biological activity. After discussing the role of nov and other CCN proteins in the development of a variety of different tissues such as kidney, nervous system, muscle, cartilage, and bone, the altered expression of the CCN proteins in various pathologies is discussed, with an emphasis on the altered expression of nov in many different tumour types such as Wilms's tumour, renal cell carcinomas, prostate carcinomas, osteosarcomas, chondrosarcomas, adrenocortical carcinomas, and neuroblastomas. The possible use of nov as a tool for molecular medicine is also discussed. The variety of biological functions attributed to the CCN proteins has led to the proposal of a model in which physical interactions between the amino and carboxy portions of the CCN proteins modulate their biological activity and ensure a proper balance of positive and negative signals through interactions with other partners. In this model, disruption of the secondary structure of the CCN proteins induced by deletions of either terminus is expected to confer on the truncated polypeptide constitutive positive or negative activities.</description><identifier>ISSN: 1366-8714</identifier><identifier>EISSN: 1472-4154</identifier><identifier>DOI: 10.1136/mp.54.2.57</identifier><identifier>PMID: 11322167</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and Association of Clinical Pathologists</publisher><subject>angiogenesis ; Animals ; Biological and medical sciences ; Cancer ; Carcinogenesis, carcinogens and anticarcinogens ; CCN ; Cell differentiation ; Connective Tissue Growth Factor ; ctgf ; cyr61 ; development ; differentiation ; fibrosis ; Gene Expression Regulation, Neoplastic ; General aspects ; Genetic aspects ; Growth Substances - genetics ; Growth Substances - metabolism ; Humans ; Immediate-Early Proteins ; Intercellular Signaling Peptides and Proteins ; Medical sciences ; Methods ; Neoplasm Proteins - genetics ; Neoplasm Proteins - metabolism ; Neoplasms - genetics ; Neoplasms - metabolism ; Neovascularization ; Nephroblastoma ; Nephroblastoma Overexpressed Protein ; Oncogene Proteins, Viral - genetics ; Oncogene Proteins, Viral - metabolism ; Oncology ; Pathology, Molecular ; Proto-Oncogene Proteins - genetics ; Proto-Oncogene Proteins - metabolism ; Review ; RNA, Neoplasm - genetics ; signalling ; Tumors ; wisp</subject><ispartof>MP. Molecular pathology, 2001-04, Vol.54 (2), p.57-79</ispartof><rights>COPYRIGHT © 2001 Journal of Clinical Pathology</rights><rights>2001 INIST-CNRS</rights><rights>COPYRIGHT 2001 BMJ Publishing Group Ltd.</rights><rights>Copyright © 2001, Journal of Clinical Pathology 2001</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b572t-8c776bb987bfa63bfbd676b99d86850e394526f4dfd0bf3c9ea5f03f75c413b93</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1187006/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1187006/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,309,310,314,727,780,784,789,790,885,23930,23931,25140,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=944940$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11322167$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Perbal, B</creatorcontrib><title>NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues</title><title>MP. Molecular pathology</title><addtitle>Mol Path</addtitle><description>The CCN family of genes presently consists of six distinct members encoding proteins that participate in fundamental biological processes such as cell proliferation, attachment, migration, differentiation, wound healing, angiogenesis, and several pathologies including fibrosis and tumorigenesis. Whereas CYR61 and CTGF were reported to act as positive regulators of cell growth, NOV (nephroblastoma overexpressed) provided the first example of a CCN protein with negative regulatory properties and the first example of aberrant expression being associated with tumour development. The subsequent discovery of the ELM1, rCOP1, and WISP proteins has broadened the variety of functions attributed to the CCN proteins and has extended previous observations to other biological systems. This review discusses fundamental questions regarding the regulation of CCN gene expression in normal and pathological conditions, and the structural basis for their specific biological activity. After discussing the role of nov and other CCN proteins in the development of a variety of different tissues such as kidney, nervous system, muscle, cartilage, and bone, the altered expression of the CCN proteins in various pathologies is discussed, with an emphasis on the altered expression of nov in many different tumour types such as Wilms's tumour, renal cell carcinomas, prostate carcinomas, osteosarcomas, chondrosarcomas, adrenocortical carcinomas, and neuroblastomas. The possible use of nov as a tool for molecular medicine is also discussed. The variety of biological functions attributed to the CCN proteins has led to the proposal of a model in which physical interactions between the amino and carboxy portions of the CCN proteins modulate their biological activity and ensure a proper balance of positive and negative signals through interactions with other partners. In this model, disruption of the secondary structure of the CCN proteins induced by deletions of either terminus is expected to confer on the truncated polypeptide constitutive positive or negative activities.</description><subject>angiogenesis</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Cancer</subject><subject>Carcinogenesis, carcinogens and anticarcinogens</subject><subject>CCN</subject><subject>Cell differentiation</subject><subject>Connective Tissue Growth Factor</subject><subject>ctgf</subject><subject>cyr61</subject><subject>development</subject><subject>differentiation</subject><subject>fibrosis</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>General aspects</subject><subject>Genetic aspects</subject><subject>Growth Substances - genetics</subject><subject>Growth Substances - metabolism</subject><subject>Humans</subject><subject>Immediate-Early Proteins</subject><subject>Intercellular Signaling Peptides and Proteins</subject><subject>Medical sciences</subject><subject>Methods</subject><subject>Neoplasm Proteins - genetics</subject><subject>Neoplasm Proteins - metabolism</subject><subject>Neoplasms - genetics</subject><subject>Neoplasms - metabolism</subject><subject>Neovascularization</subject><subject>Nephroblastoma</subject><subject>Nephroblastoma Overexpressed Protein</subject><subject>Oncogene Proteins, Viral - genetics</subject><subject>Oncogene Proteins, Viral - metabolism</subject><subject>Oncology</subject><subject>Pathology, Molecular</subject><subject>Proto-Oncogene Proteins - genetics</subject><subject>Proto-Oncogene Proteins - metabolism</subject><subject>Review</subject><subject>RNA, Neoplasm - genetics</subject><subject>signalling</subject><subject>Tumors</subject><subject>wisp</subject><issn>1366-8714</issn><issn>1472-4154</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90l1v0zAUBuAIgdgY3PADUAQCAaLFTvyRcIE0RXxNU3cD0-6M7Ry3Hokd7GTa_j0urbohVSgXTuzHb46PnGVPMZpjXLL3_TCnZF7MKb-XHWLCixnBlNxP7yVjs4pjcpA9ivESIVSRonqYHaRtRYEZP8x-Ls7O89cOhlXwqpNx9L3M_RUEuB4CxAjtm1y6Nh9XkDfNIjeyt91N7k2-BAfxQx7HMOlxCrL768zk9Gi9S582xgni4-yBkV2EJ9vxKPvx-dP35uvs9OzLt-b4dKYoL8ZZpTlnStUVV0ayUhnVsjRR123FKoqgrAktmCGtaZEypa5BUoNKw6kmuFR1eZR93OQOk-qh1eDGVJMYgu1luBFeWvHvirMrsfRXAuOKI8RSwKttQPC_U-Gj6G3U0HXSgZ-i4IjXNUZlgs83cCk7ENYZn_L0GotjTgktU28TercHrXuW_u0dGJum7_LZHp6eFnqr9_m3G6-DjzGA2R0UI7G-FKIfBCWiEJQn_Oxua27p9hYk8GILZNSyM0E6bePO1YTUBN3WaOMI17tVGX6JlMGpWJw3YnFxgU4aRsRJ8i83XvWX_yvvD4-_2hI</recordid><startdate>20010401</startdate><enddate>20010401</enddate><creator>Perbal, B</creator><general>BMJ Publishing Group Ltd and Association of Clinical Pathologists</general><general>BMJ</general><general>BMJ Publishing Group Ltd</general><general>British Medical Journal Publishing Group</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20010401</creationdate><title>NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues</title><author>Perbal, B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b572t-8c776bb987bfa63bfbd676b99d86850e394526f4dfd0bf3c9ea5f03f75c413b93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>angiogenesis</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Cancer</topic><topic>Carcinogenesis, carcinogens and anticarcinogens</topic><topic>CCN</topic><topic>Cell differentiation</topic><topic>Connective Tissue Growth Factor</topic><topic>ctgf</topic><topic>cyr61</topic><topic>development</topic><topic>differentiation</topic><topic>fibrosis</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>General aspects</topic><topic>Genetic aspects</topic><topic>Growth Substances - genetics</topic><topic>Growth Substances - metabolism</topic><topic>Humans</topic><topic>Immediate-Early Proteins</topic><topic>Intercellular Signaling Peptides and Proteins</topic><topic>Medical sciences</topic><topic>Methods</topic><topic>Neoplasm Proteins - genetics</topic><topic>Neoplasm Proteins - metabolism</topic><topic>Neoplasms - genetics</topic><topic>Neoplasms - metabolism</topic><topic>Neovascularization</topic><topic>Nephroblastoma</topic><topic>Nephroblastoma Overexpressed Protein</topic><topic>Oncogene Proteins, Viral - genetics</topic><topic>Oncogene Proteins, Viral - metabolism</topic><topic>Oncology</topic><topic>Pathology, Molecular</topic><topic>Proto-Oncogene Proteins - genetics</topic><topic>Proto-Oncogene Proteins - metabolism</topic><topic>Review</topic><topic>RNA, Neoplasm - genetics</topic><topic>signalling</topic><topic>Tumors</topic><topic>wisp</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Perbal, B</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>MP. Molecular pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Perbal, B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues</atitle><jtitle>MP. Molecular pathology</jtitle><addtitle>Mol Path</addtitle><date>2001-04-01</date><risdate>2001</risdate><volume>54</volume><issue>2</issue><spage>57</spage><epage>79</epage><pages>57-79</pages><issn>1366-8714</issn><eissn>1472-4154</eissn><abstract>The CCN family of genes presently consists of six distinct members encoding proteins that participate in fundamental biological processes such as cell proliferation, attachment, migration, differentiation, wound healing, angiogenesis, and several pathologies including fibrosis and tumorigenesis. Whereas CYR61 and CTGF were reported to act as positive regulators of cell growth, NOV (nephroblastoma overexpressed) provided the first example of a CCN protein with negative regulatory properties and the first example of aberrant expression being associated with tumour development. The subsequent discovery of the ELM1, rCOP1, and WISP proteins has broadened the variety of functions attributed to the CCN proteins and has extended previous observations to other biological systems. This review discusses fundamental questions regarding the regulation of CCN gene expression in normal and pathological conditions, and the structural basis for their specific biological activity. After discussing the role of nov and other CCN proteins in the development of a variety of different tissues such as kidney, nervous system, muscle, cartilage, and bone, the altered expression of the CCN proteins in various pathologies is discussed, with an emphasis on the altered expression of nov in many different tumour types such as Wilms's tumour, renal cell carcinomas, prostate carcinomas, osteosarcomas, chondrosarcomas, adrenocortical carcinomas, and neuroblastomas. The possible use of nov as a tool for molecular medicine is also discussed. The variety of biological functions attributed to the CCN proteins has led to the proposal of a model in which physical interactions between the amino and carboxy portions of the CCN proteins modulate their biological activity and ensure a proper balance of positive and negative signals through interactions with other partners. In this model, disruption of the secondary structure of the CCN proteins induced by deletions of either terminus is expected to confer on the truncated polypeptide constitutive positive or negative activities.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and Association of Clinical Pathologists</pub><pmid>11322167</pmid><doi>10.1136/mp.54.2.57</doi><tpages>23</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1366-8714 |
ispartof | MP. Molecular pathology, 2001-04, Vol.54 (2), p.57-79 |
issn | 1366-8714 1472-4154 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1187006 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
subjects | angiogenesis Animals Biological and medical sciences Cancer Carcinogenesis, carcinogens and anticarcinogens CCN Cell differentiation Connective Tissue Growth Factor ctgf cyr61 development differentiation fibrosis Gene Expression Regulation, Neoplastic General aspects Genetic aspects Growth Substances - genetics Growth Substances - metabolism Humans Immediate-Early Proteins Intercellular Signaling Peptides and Proteins Medical sciences Methods Neoplasm Proteins - genetics Neoplasm Proteins - metabolism Neoplasms - genetics Neoplasms - metabolism Neovascularization Nephroblastoma Nephroblastoma Overexpressed Protein Oncogene Proteins, Viral - genetics Oncogene Proteins, Viral - metabolism Oncology Pathology, Molecular Proto-Oncogene Proteins - genetics Proto-Oncogene Proteins - metabolism Review RNA, Neoplasm - genetics signalling Tumors wisp |
title | NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T12%3A51%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=NOV%20(nephroblastoma%20overexpressed)%20and%20the%20CCN%20family%20of%20genes:%20structural%20and%20functional%20issues&rft.jtitle=MP.%20Molecular%20pathology&rft.au=Perbal,%20B&rft.date=2001-04-01&rft.volume=54&rft.issue=2&rft.spage=57&rft.epage=79&rft.pages=57-79&rft.issn=1366-8714&rft.eissn=1472-4154&rft_id=info:doi/10.1136/mp.54.2.57&rft_dat=%3Cgale_pubme%3EA75453322%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70799103&rft_id=info:pmid/11322167&rft_galeid=A75453322&rfr_iscdi=true |